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Abstract
Background: The increasing use of engineered nanomaterials (ENMs) of varying physical and chemical characteristics
poses a great challenge for screening and assessing the potential pathology induced by these materials, necessitating
novel toxicological approaches. Toxicogenomics measures changes in mRNA levels in cells and tissues following
exposure to toxic substances. The resulting information on altered gene expression profiles, associated pathways,
and the doses at which these changes occur, are used to identify the underlying mechanisms of toxicity and to
predict disease outcomes. We evaluated the applicability of toxicogenomics data in identifying potential lung-
specific (genomic datasets are currently available from experiments where mice have been exposed to various
ENMs through this common route of exposure) disease outcomes following exposure to ENMs.
Methods: Seven toxicogenomics studies describing mouse pulmonary responses over time following intra-tracheal
exposure to increasing doses of carbon nanotubes (CNTs), carbon black, and titanium dioxide (TiO2) nanoparticles of
varying properties were examined to understand underlying mechanisms of toxicity. mRNA profiles from these studies
were compared to the publicly available datasets of 15 other mouse models of lung injury/diseases induced by various
agents including bleomycin, ovalbumin, TNFα, lipopolysaccharide, bacterial infection, and welding fumes to delineate
the implications of ENM-perturbed biological processes to disease pathogenesis in lungs.
Results: The meta-analysis revealed two distinct clusters—one driven by TiO2 and the other by CNTs. Unsupervised
clustering of the genes showing significant expression changes revealed that CNT response clustered with bleomycin
injury and bacterial infection models, both of which are known to induce lung fibrosis, in a post-exposure-time
dependent manner, irrespective of the CNT’s physical-chemical properties. TiO2 samples clustered separately from CNTs
and disease models.
Conclusions: These results indicate that in the absence of apical toxicity data, a tiered strategy beginning with short
term, in vivo tissue transcriptomics profiling can effectively and efficiently screen new ENMs that have a higher
probability of inducing pulmonary pathogenesis.
Keywords: Nanomaterials, Toxicogenomics, Carbon nanotubes, Carbon black, TiO2 nanoparticles, Lung disease, Lung
fibrosis
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Background
Commercial applications of engineered nanomaterials
(ENMs) continue to grow in the biomedical and manufac-
turing fields, resulting in an increased demand for synthesis
of raw ENMs, increased potential for their release into the
environment, and enhanced risk of human exposure [1].
Within the context of their nano size (1–100 nm), ENMs
can be synthesized in different shapes, and with different
surface charges and functionalization, all of which are
shown to influence ENM-induced toxicity [2]. While there
is now evidence showing that pulmonary exposure to
ENMs is more hazardous than pulmonary exposure to lar-
ger particles of the same chemical composition [3–5], the
implications of the observed response to adverse outcomes
of regulatory importance are not understood. In addition to
the inability to extrapolate toxicity data from bulk materials
to ENMs, it is also unclear as to which extent toxicity data
measured for a select set of ENMs can be generalized to
other forms of ENMs (i.e., how to group and rank ENMs
with different physicochemical characteristics). Further-
more, critical toxicological data concerning ENM exposure,
dose metrics, cellular uptake, cellular fate and transport are
missing. As a consequence, accurate predictions about the
adverse effects of ENM exposure are not possible and a
regulatory framework for human health risk assessment of
these materials has yet to be established. Given the scale at
which the field of nanotechnology is expanding, and the
immediate need to employ conventional toxicological
approaches that are time and cost intensive, new strategies
are needed to complete the safety assessment of currently
available ENMs in a timely manner [6].
Toxicogenomics investigates global responses induced
by toxic substances at the genome, transcriptome, prote-
ome, and metabolome levels. Toxicogenomics has been
used to evaluate the potential hazards of ENMs and to
identify specific ENM properties that are responsible for
their toxicity. For example, we recently employed gene ex-
pression profiling to demonstrate that nano-sized titanium
dioxide (nano-TiO2) particles of varying sizes and surface
properties induce pulmonary inflammation via the same
mechanisms-of-action; however, the study showed that
different nano-TiO2 particles vary in the magnitude of the
inflammatory response induced in a property-dependent
manner [7]. Similarly, Poulsen et al demonstrated that
pulmonary transcriptional responses indicative of lung
fibrosis varied for two carbon nanotubes (CNTs) of differ-
ent length, width, and content of metal impurities [8].
Although informative, these analyses produced long lists
of thousands of genes, proteins, and metabolites that were
identified as differentially expressed in exposed versus
control tissues, making it difficult to distinguish between
genes that play a role in the observed biological response
from those that represent spurious events. A greater chal-
lenge lies in the identification and discrimination of genes
that define benign tissue defense mechanisms from those
potentially important for the progression of adverse out-
comes and diseases, as many disease-causing genes are
often involved in host defense. In the case of ENMs, the
identification of essential transcriptional signatures of dis-
eases or pathogenesis early after exposure will not only
provide insight into the underlying mechanisms of toxic-
ities, but will also aid in developing rapid screening tests
for prioritizing ENMs for further testing, identify disease
producing ENMs, and enable the identification of markers
of exposure and/or effect that can be potentially used for
human biomonitoring and surveillance.
Nanotoxicology research has thus far not revealed tox-
icities or pathologies unique to ENMs, suggesting that
the adverse outcomes of exposure to ENMs can be
anticipated based on existing knowledge of the toxicity
or pathology induced by analogous particles, chemicals,
or substances [9]. Given the number of toxicogenomics
studies that have investigated toxicant-induced lung
diseases, in the present study we sought to define the
critical gene expression fingerprints of lung events and
diseases that are overrepresented in the lung transcrip-
tional responses induced by ENMs. We conducted a
meta-analysis of previously published gene expression
microarray data from mouse lungs exposed to multi-
walled CNTs (MWCNTs), carbon black (CB), and nano-
TiO2 of varying properties, and of publicly available gene
expression microarray data of lung diseases induced by
various exogenous agents including bleomycin, ovalbu-
min, TNFα, LPS, bacterial infection and welding fumes.
Meta-analysis of the intersections of transcriptional
changes induced by ENM and lung disease datasets were
examined to identify signatures or features that are asso-
ciated with ensuing lung pathology.
The study is a proof-of-principle and demonstrates the
potential application of toxicogenomics data in identify-
ing disease causing ENMs. By using publicly available
lung injury models and ENMs that are known to induce
lung events, we demonstrate how data derived from tox-
icogenomics as a stand-alone technique can inform
potential disease potencies of ENMs that have not yet
been extensively studied using conventional apical end-
points. The analysis was restricted to mouse models to
minimize the loss of relevant biological information dur-
ing the statistical normalization of cross-species data.
The study analysis was also restricted to only those data-
sets that are readily available for download from public
repositories and consisted of more than one dose in
addition to controls.
Methods
Study selection
Table 1 summarizes the studies that were included in
this analysis [7, 8, 10–19], including experimental
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details such as the nanomaterial/chemical, route of
exposure, strain of mouse, dose, post-exposure time
points investigated and microarray platform used.
Since inhalation is an important route of exposure for
ENMs in occupational settings, and since the pul-
monary transcriptomic responses following exposure
to some ENMs are fairly well characterized, studies
that investigated the gene expression profiles of pul-
monary responses to ENMs and lung disease models
were used in the meta-analysis. The physico-chemical
properties of the ENMs are summarized in Table 2.
Data were obtained from the Gene Expression Omni-
bus (GEO) (http://www.ncbi.nlm.nih.gov/geo). The ul-
timate goal of this meta-analysis was to investigate
the associations between gene expression profiles of
lung tissue exposed to ENMs and of lung tissue from
models of known pulmonary diseases.
Data processing and normalization
Due to differences in microarray platforms used across
the chosen studies, all gene expression data were nor-
malized using a common statistical method. The log2
transformation was applied to all signal intensity mea-
surements. For two color microarray studies, the LOW-
ESS normalization method [20], using the R statistical
software environment [21] was applied. For studies using
Affymetrix GeneChips®, the RMA normalization was ap-
plied using the justRMA function in the affy R package
[22]. Quantile normalization was applied for studies
using Illumina beadchip. This was done using the lumiN
function in the lumi R package [23].
Probes with technical replicates were then averaged
using the median. The data for each study were then
merged to their appropriate annotation files to obtain
gene symbols. Probes with the same gene symbol were
Table 1 A list of the studies that were included in the meta-analysis and the experimental details
Reference Nanomaterial/Chemical Route of
exposure
Mouse strain Dose Post-exposure
time point
Array platform GSE
Poulsen et al.
(2015) [8]
Carbon nanotubes Intratracheal Adult C57BL/6 Single dose of 18,
54, 162 μg/mouse
1, 3, and
28 days
Agilent whole
genome
GSE35284
Bourdon et al.
(2012) [10]
Carbon black Intratracheal Adult C57BL/6 Single dose of 18,
54, 162 μg/mouse
1, 3, and
28 days
Agilent whole
genome
GSE35193
Halappanavar
et al. (2011) [13]
Nano titanium dioxide Inhalation Adult C57BL/6 1 h daily for 11
consecutive days
to 42.4 mg
5 days Agilent whole
genome
GSE19487
Guo et al.
(2012) [14]
Carbon nanotubes Pharyngeal
aspirations
Adult C57BL/6 Single dose of 0,
10, 20, 40, or 80
μg of CNT/mouse
1, 7, 28, and
56 days
Agilent whole
genome
GSE29042
Reference not
available
Bleomycin Intratracheal Adult Balb-c
and C57BL6
Single dose of
0 and 1.5 U/kg
body weight
24 h, 72 h,
10 day and
14 days
Affymetrix
murine genome
GSE485
Erdely et al.
(2012) [15]
Gas metal arc - stainless
steel welding fume
Inhalation Adult C57BL6 0 or 40 mg/m3,
3 h daily for 10
consecutive days
4 h, 14 days,
28 days
Illumina mouse
bead array
GSE34056
Zeidler-Erderly
et al. (2010) [16]
Gas metal arc—stainless
steel welding fume
Pharyngeal
aspiration
Adult A/J or
C57BL/6 J
Four doses of
85 mg/kg
4 and
16 weeks
Illumina mouse
bead array
GSE20174
Lewis et al.
(2008) [17]
12 different lung disease model
datasets including bleomycin,
Th2 responses, and infection
models
Differs with
the model of
lung disease
Differs with
the model of
lung disease
Differs with the
model of lung
disease
Differs with
the model
of lung disease
UCSF &Mm
mouse oligo
array
GSE4231
Halappanavar
et al. (2015) [7]
Nano titanium dioxide Intratracheal Adult C57BL/6 Single dose
of 18, 54, 162,
or 486
μg/mouse
1 and 28 days Agilent whole
genome
GSE60801
Husain et al.
(2015) [19]
Carbon Black Intratracheal Adult C57BL/6 Single dose of
162 μg/mouse
3 h, and 2, 3,
4, 5, 14, and
42 days
Agilent whole
genome
GSE68036
Rahman et al.
(manuscript
in preparation)
Carbon nanotubes Intratracheal Adult C57BL/6 4 doses of 128 or
47.5 μg/mouse
per week
60 days Agilent whole
genome
GSE65623
Thomson et al.
(2012) [18]
Lung-specific TNFα
over-expression
N/A Adult C57BL/6
and transgenic
mice
N/A N/A Agilent whole
genome
GSE11037
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then averaged using the median. Experimental conditions
with biological replicates were averaged using the median.
The data were further normalized by subtracting the me-
dian average of the appropriate control samples resulting
in the log2 fold change for each experimental condition.
The control samples were then removed from the data
set. All studies were then merged together using the gene
symbol for data analysis.
A total of 2334 gene symbols were in common across
all platforms with 190 experimental conditions relative
to controls. The resulting data matrix consisting of gene
symbols were filtered based on the number of experi-
mental conditions exceeding a log2 (1.5 fold) cut-off.
Although the use of fold change ranking in conjunction
with a flexible (non-stringent) p-value threshold is sug-
gested in order to generate reproducible differentially
expressed gene lists [24], no numeric values as fold
change or p-value cut-offs have been specifically pre-
scribed. Using a pre-determined stringent cut-off for fold
change to identify differentially expressed genes, espe-
cially in an experiment where the objective is to deter-
mine the effects following exposures to ENMs of varying
potency and across several doses (including low doses
where not many changes are expected), may comprom-
ise sensitivity and miss some biologically relevant genes
that have low fold changes. For this reason, we have
used the fold change of 1.5. Furthermore, the filtering
helped remove non-informative genes that could distort
correlations between experimental conditions. Gene
symbols that had more than 5 experimental conditions
that exceeded this cut-off (in absolute value) were
retained for hierarchical cluster analysis, which resulted
in 945 gene symbols.
Dendrogram analysis
Hierarchical clustering is a statistical technique that
groups experimental conditions based on distances.
Hierarchical cluster analysis was conducted on normal-
ized expression levels of the 945 gene symbols identified
above. Here, the 1-Pearson correlation dissimilarity
metric was used. The average linkage function, which
determines how distances between sets of observations
are calculated, was used and the analysis was conducted
using the R software package.
Gene Ontology Analysis
A shortlist of differentially expressed genes (DEGs) that
showed differential expression in at least 50 % of the ex-
perimental conditions within the respective cluster was
used in the analysis, so that only genes that are involved
in the majority of experimental conditions were exam-
ined. To determine the biological relevance of the DEGs
identified in the disease clusters, an analysis of the gene
ontologies (GOs) enriched within the shortlisted genes
of each cluster was performed. This analysis used the
gene ontology consortium database, and was performed
using the Cytoscape (Cytoscape Consortium) software
app ClueGo (Laboratory of Integrative Cancer Immun-
ology, Paris, France) [25, 26]. The enrichment analysis
used gene associations based only on experimental evi-
dence. GOs were included if they had a minimum of 3
genes expressed and if a minimum of 4 % of the GO was
represented. To reduce the redundant GOs, GoFusion
was enabled in the ClueGo software, and GOs were col-
lapsed back to parent ontologies if all of the DEGs from
the Parent and child GOs were the same. For ball and
Table 2 The physico-chemical properties of the ENMs investigated in the studies listed in Table 1
Reference GSE Name in study Producer (particle name) Size BET (m2/g)
Poulsen et al. (2015) [8] GSE35284 CNTsmall Nanocyl (NC-7000) 0.85 ± 0.457 μm × 11 ± 4.5 nm 245.8
CNTlarge IO-LE TECNanomaterials
(CP-0006-SG)
4.05 ± 2.40 μm × 67 ± 2.40 nm 14.6
Bourdon et al. (2012) [10] GSE35193 CBNPs Evonik/Degussa (Printex 90) 14 nm 295–338
Halappanavar et al. (2011) [13] GSE19487 NanoTiO2 Kemira (UV-titan L181) 20 nm 107.7
Guo et al. (2012) [14] GSE29042 MWCNT Mitsui & Company (MWCNT-7) 3.86 μm × 49 ± 13.4 nm not listed in
study
Halappanavar et al. (2015) [7] GSE60801 TiO2NP
10.5 NanoAmor (NRCWE-030) 10.5 nm 139.1
TiO2NP
38 Nabond (NRCWE-025) 38 nm 28.2
TiO2NP
10 NanoAmor (NRCWE-001) 10 nm 99
TiO2NP
10+ NanoAmor (NRCWE-002) 10 nm 84
TiO2NP
20.6 Kemira (UV-Titan L181) 20.6 nm 107.7
Husain et al. (2015) [19] GSE68036 CBNPs Evonik/Degussa (Printex 90) 14 nm 295–338
Rahman et al. (manuscript in preparation) GSE65623 Mitsui XNRi-7 Mitsui & Company (NRCWE-006) 5.7 ± 0.49 μm × 74 (29–173) nm 26
CNT 401 OECD WPMNM (NM-401) 4.0 ± 0.37 μm × 67 (24–138) nm 18
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stick diagrams, a 50 % overlap of DEGs was used as the
threshold for grouping of the GOs.
Upstream Regulator analysis
Ingenuity Pathway Analysis (IPA) software (Qiagen Sili-
con Valley) was used to determine the upstream regula-
tors of gene expression that might contribute to the
gene expression profiles identified in the disease clusters.
Specifically, the upstream regulator analysis tool was
used, and only gene products, miRNA, and proteins
were selected. Only upstream regulators with z-scores of
3 or more and with p < 0.001 were included.
Fibrosis associated genes
The gene list fibrosis of the lung from the IPA archives
was used to identify genes associated with pulmonary fi-
brosis. Tables and heat maps were constructed using this
list as a reference.
Results
Comparison of transcriptomic datasets of ENM exposure
versus models of lung disease
To understand if gene expression signatures obtained
from the lungs of mice exposed to nano TiO2, CB or
MWCNTs may be associated with specific lung diseases,
a meta-analysis was performed that included 12 studies
that investigated lung injury or lung diseases and ENM-
induced pulmonary responses (Table 1). A final data set
consisted of ~700 individual microarray hybridizations
representing 137 experimental conditions. Due to differ-
ences in microarray platforms used to collect the gene
expression data included in this meta-analysis, only
those genes that were consistently found on all of the
platforms were used to derive a list of 2334 DEGs (Add-
itional file 1: Table S1). A gene showing expression
changes >1.5 relative to matched controls in more than
5 of the 137 total experimental conditions was consid-
ered to be significant and was included in the meta-
analysis. Through this criterion, a total of 954 DEGs
were derived. Hierarchical clustering of the 954 genes
was conducted to visualize the relationship between the
different experimental datasets (Fig. 1).
The key findings of this analysis, which are summa-
rized in Fig. 1, reveal the following: 1) there were tran-
scriptional features distinct to the response induced by
bacterial infection, bleomycin induced lung injury, T
helper type 2 lymphocytes (Th2)-mediated allergic re-
sponse and ENMs; 2) all experimental samples exposed
to nanoTiO2 clustered separately (Fig. 1, nanoTiO2 clus-
ter) from the MWCNT-exposed samples (Fig. 1,
MWCNT cluster); and, 3) only MWCNT datasets clus-
tered with lung disease models (Fig. 1, MWCNT cluster).
Within the MWCNT cluster, two sub-clusters were
identified: 1) the cluster colored in pink, which included
datasets from the bleomycin-induced injury and bacter-
ial infection models; and 2) the blue cluster which con-
sisted of the dataset from the ovalbumin sensitization
model characteristic of a Th2 response. Both the pink
and blue clusters contained experimental samples from
studies of MWCNTs with different physic-chemical
properties and included a range of doses. The clustering
of the MWCNT-exposed samples within these sub-
clusters was mainly associated with different post-
exposure time points at which the analysis was con-
ducted. The MWCNT data sets in the pink cluster
alongside the bleomycin/bacterial studies were primarily
from the 24 h post-exposure time point; whereas, those
found in the blue cluster (together with Th2 response
studies) were predominantly from the 14, 28 and 56 days
post-exposure time points. A 3 day post-MWCNT ex-
posure time point was also included in the meta-
analysis. These datasets did not show distinct clusters
and were scattered across the MWCNT cluster, with 4
of the 6 experimental groups clustering in pink with the
bleomycin/bacteria models. The analysis suggests that
the initial response to MWCNT administration is similar
to lung responses observed following bacterial challenge
or following exposure to a damaging substance like bleo-
mycin; whereas, later responses to MWCNT are similar
to Th2 response induced following exposure to aller-
gens. Th2-induced gene expression of several cytokines,
chemokines and growth factors is known to play a crit-
ical role in the progression of lung fibrosis [27], a lung
disease observed at 14 or 28 days following exposures to
MWCNTs [28]. Examining the genes that drive this
clustering may provide insight into the biological pro-
cesses engaged in these two distinct phases of the pul-
monary responses to MWCNTs.
In general, the clusters showed clear associations be-
tween datasets from MWCNT-exposed lungs and lung
disease models; however, some individual samples from
the bleomycin injury, bacterial infection, nanoTiO2, and
arc-stainless steel studies clustered under a separate
branch at the distal end of the MWCNT cluster. The
clustering of these samples may reflect differences in the
individual animal responses. Similarly, several CB and
nanoTiO2 groups including the only inhalation study de-
scribing responses to inhaled nanoTiO2 consisting of
single dose and single post-exposure time point were
clustered together in between the pink and the blue
cluster. Although it is tempting to speculate that the
route of exposure (inhalation vs instillation) may have
something to do with this unique clustering in the case
of the nanoTiO2 inhalation study group, detailed analysis
of DEGs in the cluster did not reveal such unique fea-
tures. More studies systematically investigating the re-
sponses following exposure to particles delivered via two
different administration routes are required.
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Fig. 1 (See legend on next page.)
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Additionally, some CB experimental groups were ob-
served in the pink (bleomycin/bacteria) and the blue (Th2
response) sub-clusters. These findings imply that tran-
scriptional responses to carbon-based nanoparticles (CB
and MWCNTs) may share some similarities; however, we
caution that the results of the CB-exposed samples are in-
consistent. Transcriptional response to stainless steel also
clustered separately. The closest nodes to stainless steel
were acute exposure to bleomycin and acute exposures to
nanoTiO2. Since only MWCNT datasets showed clear
association with the lung disease models, the analysis
described below focused on the pink and blue sub-
clusters.
GO functional analysis of DEGs intersecting bacteria/
bleomycin (pink) and Th2 response (blue) clusters
It is expected that the essential features of any biological
response, including a disease phenotype, are overrepre-
sented in the affected/exposed tissues relative to the un-
affected/unexposed control tissues. To identify these
transcriptional features we explored transcriptional simi-
larities of the lung disease models and MWCNT-
induced pulmonary responses, by investigating the genes
in common with the various experimental conditions
that made up the pink and blue sub-clusters. A shortlist
of upregulated and downregulated genes was generated
for each intersection, which consisted of genes that were
significantly altered in at least 50 % of the datasets
within that specific cluster. Gene expression fold changes
were used to generate a heat map for each cluster (Figs. 2
and 3). The shortlist of genes in the bleomycin/bacterial
cluster (pink) consisted of 79 upregulated and 21 down-
regulated genes (Fig. 2). The Th2 response cluster (blue)
consisted of 53 upregulated and 3 downregulated genes
(Fig. 3). There was a high degree of overlap in genes
between the different biological functions identified.
In order to investigate the type of biological processes
perturbed by the DEGs that are common in either the
pink bleomycin/bacteria or the blue Th2 response sub-
clusters, the short list of genes was analyzed using the
Cytoscape app, ClueGo. This analysis takes into account
the experimentally curated gene ontologies specific to
biological processes. Because the pink cluster consists of
acute post exposure time points and the blue cluster
consists of longer post-exposure time points, this
analysis effectively differentiates biological processes
engaged in the early and late phases of the response to
MWCNT, in addition to highlighting the processes that
overlap with lung disease models.
Biological processes/functions perturbed in bacteria/
bleomycin cluster
The short list of DEGs from the pink cluster was enriched
in host defense GOs and the response to specific stimuli
(Fig. 2). Specifically, defense response (GO:0006952), which
indicates that mechanisms involved in host-defense
against invasive agents were engaged, and response to
wounding (GO:0009611), implying that MWCNTs are
damaging to the lung environment at early time points,
were enriched. The other enriched biological processes
included response to organic substance (GO:0010033) and
response to oxygen containing compound (GO:1901700),
suggesting a commonality between the response to this
broad group of stimuli and MWCNTs. Five genes from
the shortlist, Ccl2, Hif1a, Myd88, Socs3, and Tnf, were
common to all of these GOs. In addition, regulation of
myoblast differentiation (GO:0045661) was enriched, but
its involvement in the pulmonary response to MWCNT is
not clear. Forty-six of the upregulated genes were not asso-
ciated with any enriched GOs in this analysis. Enrichment
analysis of the downregulated genes identified blood circu-
lation (GO:0008015), chemical homeostasis (GO:0048878),
and stem cell development (GO:0048864) processes to be
altered, which indicates that homeostatic processes like the
circulation of blood and developmental processes may be
disrupted in the lungs by acute MWCNT exposure as it is
in bacterial infection and bleomycin exposure. Twelve of
the downregulated genes could not be associated with any
enriched GO.
Biological processes/functions perturbed in Th2 response
cluster
Similar to the pink cluster, the enriched GOs in the
blue cluster also included in host-defense mechanisms
(Fig. 3), such as defense response (GO:0006952), inflam-
matory response (GO:0006954), granulocyte chemotaxis
(GO:0071621), regulation of leukocyte mediated immunity
(GO:0002703), and positive regulation of endocytosis
(GO:0045807). GOs related to a broad range of immune
functions were also enriched, including response to other
(See figure on previous page.)
Fig. 1 NanoTiO2 and MWCNTs clustered separately, and MWCNTs were further differentiated by the post-exposure time period. Hierarchical clustering was used
to visualize the differential expression of 2334 common genes across the microarray platforms used in this study and across 137 different experimental
conditions from 12 studies. The figure depicts the clustering of individual arrays performed on RNA isolated from murine lung tissue within each respective
study. Two distinct clusters were identified, with nanoTiO2 arrays and MWCNT arrays clustering separately. The MWCNT cluster could be further divided
into two sub-clusters: (1) arrays from MWCNT exposure models were correlated with those from bacteria and bleomycin exposure models (pink); and (2)
expression profiles from MWCNT exposure models were correlated with arrays from a Th2 model (blue). Other nanomaterial exposure models did not
cluster in notable patterns
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Fig. 2 The bacteria/bleomycin cluster was enriched in DEGs associated with defensive responses to various stimuli. A short list of genes was generated for
the bacteria/bleomycin cluster (highlighted in pink in Fig. 1). Genes that were differentially expressed in at least 50 % of the arrays that make up the
cluster were included in the shortlist. The ClueGO app for Cytoscape software with GO Fusion was utilized to identify biological functions that were
enriched in the shortlist and reduce any repetitive GOs. GOs were collapsed back to their parent GOs to further simplify data presentation. A heatmap
was generated to visualize the cluster’s shortlist, organized by biological function
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Fig. 3 Enrichment analysis of the biological functions in the Th2 cluster involved the immune response. A short list of genes was generated for the Th2
response cluster (highlighted in blue in Fig. 1). Genes that were differentially expressed in at least 50 % of the arrays that make up the cluster were
included in the shortlist. The ClueGO app for Cytoscape software with GO Fusion was utilized to identify biological functions that were enriched in the
shortlist and reduce any repetitive GOs. GOs were further collapsed back to their parent GOs to further simplify data presentation. A heatmap was
generated to visualize the cluster’s shortlist, organized by biological function
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organism (GO:0051707), positive regulation of immune re-
sponse (GO:0050778), and regulation of cytokine produc-
tion (GO:0001817). In addition, GOs related to the
adaptive immune response such as lymphocyte mediated
immunity (GO:0002449) were also enriched. Adaptive im-
munity and lymphocyte function are key components that
characterize the Th2 response and this GO represents an
important overlap between MWCNT exposure and the
Th2 response model. Upregulated genes associated with
these immune response GOs included C1qa, C3, Ccl2,
Ccl3, Cxcl1, Cxcl9, Fcer1g, Fcgr2b, Fcgr3, Irf7, and Slc11a1.
The inorganic anion transport (GO:0015698) and regula-
tion of myoblast differentiation (GO:0045661) ontologies
were also enriched in this analysis, although their rele-
vance to the response to MWCNT is less intuitive. The
enrichment of positive regulation of response to stimulus
(GO:0048584) and response to wounding (GO:0009611)
was also observed, which suggested that damage to the
pulmonary environment is activating repair mechanisms
at early and late time points; however, a large number of
adaptive immune mechanisms are engaged at later phases
of the response to MWCNTs. Only 3 genes were down
regulated in this shortlist and enrichment analysis of such
a small list did not produce any meaningful results.
Visual inspection of the heat maps (Figs. 2 and 3) re-
veals a pattern that is consistent with a dose response in
gene expression changes at later post-MWCNT expos-
ure time points. Although the pink cluster showed simi-
lar transcription levels across all of the arrays (Fig. 2),
gene expression patterns in the blue cluster revealed
time and dose-dependence (Fig. 3). Specifically, samples
exposed to lower doses (40 μg/mouse or less) MWCNTs
analyzed at 56 days post-exposure showed less similarity
in expression changes with the Th2 response model. In
contrast, mice exposed to more than 40 μg/mouse
showed a higher degree of similarity in transcriptional
profiles to the Th2 response models at 3, 7 and 28 days
post-exposure time points. Thus, there was a dose and
time dependency in association of MWCNT samples
with disease models.
Analysis of upstream regulators controlling the perturbed
processes in both bacteria/bleomycin and Th2 response
clusters
IPA was used to identify the upstream transcriptional
regulators potentially controlling the observed gene ex-
pression changes in the pink and blue clusters. Upstream
regulators showing a Z-score above 2.0 are shown in
Fig. 4a. Interestingly, a number of genes known to regu-
late inflammatory processes (Tnf, Ifng, and Il1b), and
genes involved in regulating cell proliferation and
growth (Tgfb1 and Csf2), had the highest Z-scores for
both sub-clusters. This suggests that the two clusters are
regulated by similar processes. A Venn analysis of the
upregulated genes in the shortlists from both sub-clusters
confirmed a total of 22 overlapping genes that were upreg-
ulated in both clusters (Fig. 4b). No such analysis could be
conducted for the down regulated genes, as the blue cluster
shortlist contained only 3 down regulated DEGs. Further
analysis of the 22 overlapping genes using ClueGo/Clupedia
network analysis showed that these genes are mainly associ-
ated with recruitment of leukocytes and were grouped
under positive regulation of transport (GO:0051050),
leukocyte chemotaxis (GO:0030595), myeloid leukocyte
migration (GO:0097529), and regulation of cytokine produc-
tion (GO:0001817) (Fig. 4c). The Ccl2, Ccl3, Fcgr2b, and
Fcgr3 genes were common to all GO categories. Collect-
ively, this analysis suggests that inflammation and inflam-
mation related genes govern the responses observed in the
two sub-clusters (pink and blue). These results suggest that
both phases of the response to MWCNT are driven by
inflammatory mediators despite distinct clustering of the
early and late phases of the MWCNT with different lung
disease models, and that several of these mediators are con-
tinually expressed.
Gene expression changes associated with lung fibrosis
The lung injury models including bleomycin, Th2
response-mediated allergy, and bacterial infection are all
known to cause lung fibrosis [27]. Similarly, exposure to
different variants of MWCNTs induces pulmonary fibro-
sis in several studies [28, 29]. In fact, lung fibrosis is a
well-characterized adverse pulmonary outcome induced
by MWCNTs. Thus, the short lists of intersecting genes
were examined for their direct association with lung
fibrosis.
Lung fibrosis has been extensively studied and several
of the genes involved in this process have been identi-
fied. Using the IPA pathway and network database, a list
of 105 genes associated with fibrosis of the lung network
was created. Next, the gene lists from the pink and blue
clusters, as well as genes identified in the upstream regu-
lator analysis, were overlaid onto the IPA fibrosis net-
work gene list. This analysis identified 23 specific genes
associated with both clusters that are directly relevant to
the progression of lung fibrosis (Fig. 5a). Of particular
interest were Arg1, C3, and Ccl17, genes which were in-
creased at 7, 28, and 56 days post-exposure time points
in MWCNT studies, when fibrosis is observed histologi-
cally in this model [8]. Interestingly, Arg1, C3, and Ccl17
are all genes considered to be biomarkers of alternatively
activated macrophages, a cell type that requires Th2-
regulated cytokines for its differentiation, and that also
have been implicated in the progression of pulmonary
fibrosis [30, 31].
Meta-analysis of the gene expression data derived from
various studies identified MWCNTs as potential
fibrosis-inducing substances that could possibly mediate
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their fibrotic response via the Th2-mediated signaling.
However, given the variability in the study designs, doses
used and statistical normalization processes employed,
the genes in the cluster shortlists would not be expected
to include all of the potential pro-fibrotic genes induced
by MWCNT exposure. Although, the cluster analysis
Bacteria/Bleomycin
Cluster Th2 Response
Cluster
56 22 31
A
B
C
Fig. 4 Upstream regulator analysis identifies inflammatory mediators similar to both clusters. a IPA software was used to identify the upstream regulators of
the gene expression profile of the pink and blue clusters. b A Venn diagram was constructed to investigate the similarity between the genes that were
increased in each of the shortlists, demonstrating the overlap between them. c The Cytoscape apps ClueGO and CluePedia created a visual network of the
biological functions enriched in these overlapping genes and identified specific genes that are common to different biological functions. All but two of the
GOs were grouped together based on similar gene expression patterns and are highlighted in green, with the positive regulation of transport GO being the
most significantly enriched biological function in the group
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may be used to identify a portion of the biological
response that is involved in fibrotic pathogenesis, it is
likely that additional genes are involved. As such, several
pro-fibrotic genes that may have been altered in re-
sponse to nanoTiO2 and CB exposures may not have
been measurably altered in this study, this likely resulted
in differential grouping of these substances.
To investigate this hypothesis, the list of IPA’s fibrosis of
the lung disease network genes was overlaid onto the day
1 and day 28 DEG lists of mouse lungs exposed to 162 μg
of MWCNTs, nanoTiO2, or CB (from studies that were
included in the meta-analysis) [8, 10, 11]. These genes
were divided into three groups depending on whether the
genes are expected to increase fibrosis, decrease fibrosis,
or if the direction of change is uncertain (Fig. 5b). The
genes highlighted in yellow were the ones identified
through the cluster analysis (Fig. 5a). This analysis
revealed additional genes from the MWCNT datasets
associated with fibrosis but not many genes from the
nanoTiO2 and CB studies. This expanded list of genes
included Mmp12, Spp1, Pla2g4a, Igf1, and Ptgir which
were expressed at greater levels in MWCNT exposed
lungs at 28 days post-exposure.
Discussion
Microarray technology has been extensively used to
investigate the relationship between gene expression
profiles and molecular mechanisms underlying diseases.
In this study, we compared pulmonary gene expression
profiles derived from mice exposed to different ENMs to
those induced by chemical substances or pathogens
causing lung diseases. Our meta-analysis demonstrates a
feasible approach for the application of global gene
expression profiling to identify the potential of ENMs to
cause pulmonary pathogenesis. By using a variety of lung
models of inflammatory diseases, we identified common
transcriptional changes between lung diseases and ENM-
induced lung responses. This allowed us to bin MWCNTs
as potentially disease-causing ENMs separately from the
nanoTiO2 and CB, as ENMs not associated with lung
disease at the concentrations and time points examined in
this study. This work also revealed potential mechanisms
by which MWCNTs induce lung fibrosis, and identified a
suite of marker genes that may serve as predictors of lung
fibrosis.
Several studies argue that inflammation does not play
a role in pulmonary fibrosis in general [32, 33]. This is
mainly due to the lack of an influx of inflammatory cells
observed in patients presenting with lung pathology in
parallel with the lack of efficacy of immunosuppressive
drugs in fibrosis patients [34, 35]. In line with this argu-
ment, in MWCNT-exposed mice presenting with the
fibrotic phenotype (studies included in the analyses),
BAL cellular influx recedes (but does not completely
reverse) with time and fibrotic lesions do not present
inflammatory characteristics [8]. However, the gene
expression data shown here suggest otherwise and pro-
vide clues as to how the process of inflammation may
participate in the fibrotic pathology. The meta-analysis
showed that pulmonary gene expression signatures
induced by MWCNTs were similar to patterns of bacter-
ial, bleomycin, and Th2-mediated allergic response models
that induce robust pulmonary inflammation, and revealed
altered gene expression of a large suite of inflammatory
cytokines and chemokines across the acute and sub
chronic post-exposure time points. The results also
showed that the upstream regulators governing the altered
gene expression profiles involved the transcriptional fac-
tors responsible for regulating inflammation.
In addition to cytokines, genes involved in alternatively
activated (M2) macrophages resulting from polarized T-
cell response (eg. Arg1, C3, and Ccl17) were upregulated
in MWCNT-exposed lung datasets. M1 and M2 macro-
phage types are involved in mediating pulmonary
inflammatory responses at different stages of the re-
sponse [36]. M1 macrophages kill invading pathogens or
injured cells and produce pro-inflammatory cytokines
[36]. In contrast, activated M2 macrophages secrete
anti-inflammatory cytokines, regulate M1-mediated in-
flammatory responses, aid in clearance of cellular debris,
and promote angiogenesis, tissue remodeling, and repair
[36]. Upregulation of Arg1, C3, and Ccl17 potentially
results in the activation of the M2 phenotype, and sim-
ply reflects the transition to a different functional state
(from innate immune to adaptive response) in cells bat-
tling persistent injury inflicted by residual MWCNTs.
This was also evident by the temporal nature of the as-
sociation between the MWCNT-induced lung responses
and disease models; early responses (24 h, 3days) had
transcriptional profiles that were consistent with bacter-
ial- or bleomycin-induced injury responses, and the later
(See figure on previous page.)
Fig. 5 The MWCNT sub-clusters include pro-fibrotic genes that can differentiate MWCNT from less fibrotic nanomaterials. a A list of fibrosis genes was obtained
from the IPA database and the overlapping genes shortlisted in the pink and blue clusters, as well as the genes identified as upstream regulators of the
pink and blue cluster shortlists, are indicated. b The fibrosis gene list from IPA was also applied to gene shortlists from CNT, TiO2, and CB datasets that
were included in this meta-analysis with the same dose and time points to show the differences in gene expression between MWCNTs and other less
fibrotic nanomaterials. Genes from Fig. 5a are highlighted in yellow
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responses (28days) suggested an association with Th2-
mediated response, reflecting a transition from early
innate immune response to later adaptive immune
responses, respectively. Thus, profuse inflammation,
continuing injury, and tipping of the delicate balance be-
tween pro- and anti-inflammatory mediators results in
the activation of alternate cell types and secretion of
pro-fibrotic molecules which creates a microenviron-
ment conducive for the development of lung fibrosis.
The inflammatory process has been implicated in lung
fibrosis induced by crystalline silica and asbestos [37],
both of which are shown to accumulate in alveolar
macrophages resulting in the activation of an inflamma-
tory cascade that eventually results in lung fibrosis.
MWCNTs are suggested to behave like asbestos due to
their fiber like structures [38]. Collectively, these results
suggest an important role for inflammation in ensuing
lung fibrosis induced by MWCNTs.
Although nanoTiO2 and CB exposure also induce lung
inflammation and alter the expression of several pro-
inflammatory genes [39], mice exposed to these ENMs
did not show a clear association with the disease models.
There are many differences in the characteristics of
inflammation produced by nanoTiO2 and CB, including:
1) CB/nanoTiO2 exposure causes significantly less in-
flammation than MWCNT in mice exposed at similar
exposure doses and sampling regimens; 2) nanoTiO2and
CB induced inflammation is predominantly neutrophilic;
whereas, MWCNT induced inflammation involves mul-
tiple cell types; 3) with the exception of the highest doses
examined, BAL cellular influx significantly declines 28days
post-exposure following nanoTiO2 and CB exposure, it is
less reduced in mice exposed to MWCNT; 4) gene expres-
sion patterns in nanoTiO2 or CB exposed samples are
mainly associated with acute innate response; and, 5) the
magnitude of expression change for any given gene is rela-
tively lower for nanoTiO2 or CB exposed samples com-
pared with MWCNTs and the majority of these changes
are reversed by 28 days post-exposure [8, 10, 11]. Al-
though some CB samples were interspersed with the dis-
ease models, the response varied within specific
experimental conditions and lacked consistency. Neither
nanoTiO2 nor CB have been shown to induce lung fibrosis
at the doses or time points analyzed in this study.
The other interesting observation, though subtle, was
that the experimental conditions from the welding fumes
study clustered differently in a manner that seemed to
depend on their lung administration methods (aspiration
versus inhalation). However, the two studies were con-
ducted at different times and varied in the experimental
design including the doses administered. In the context of
ENMs, it can be expected that lung responses to ENMs
introduced via inhalation, aspiration or intratracheal
deposition may be different because of the differences in
the deposited dose and ENM distribution in lungs. How-
ever, we have previously shown that lung inflammatory
responses to surface-coated TiO2NPs deposited in mouse
lungs via intratracheal instillation or inhalation are similar
[11]. Jackson et al did not observe differences in the lung
distribution or effects in mice exposed to carbon black par-
ticles via intratracheal instillation or inhalation [40]. Future
studies directly comparing the pulmonary toxicogenomics
responses from mice exposed to ENMs via inhalation or
other lung administration routes are warranted. Currently,
such a comparison is not possible as lung toxicogenomics
data from inhalation models are not available.
Other groups have employed global gene expression
profiling to identify signatures predictive of lung cancer
for ENMs. Pacurari et al. showed changes in the ex-
pression of a select set of lung cancer biomarker genes
following exposure to MWCNTs and suggested a link
between MWCNT-induced lung inflammation, fibrosis,
and cancer [41]. A follow up study by Guo et al. con-
ducted genome-wide gene expression profiling of
MWCNT-exposed mouse lungs and compared the gene
expression profiles to human lungs derived from lung
cancer patients to predict lung cancer progression by
correlating mouse gene expression data with expression
in patient lungs [14]. A recent study by Sargent et al
showed that Mitsui-7, a rigid, rod-like fiber acts as a
cancer promoter; however, there is no current evidence
to support the occurrence of lung cancer following ex-
posure to all types of MWCNTs [42].
In addition to lung cancer and fibrosis, MWCNTs
may also contribute to other lung diseases, though little
data exist to support this possibility. Consistent with
the findings of our meta-analysis demonstrating simi-
larities in the transcriptional response of MWCNT-
exposed mice and Th2 disease models, MWCNT have
been shown to stimulate and exacerbate allergic airways
[28, 43–45]. These animal models demonstrate an
increase in allergic inflammation, mucus hyperplasia,
and fibrotic airway when MWCNT are administered
along with an allergen or surrogate allergen. These ob-
servations from allergy models highlight an important
consideration for the toxic properties of MWCNTs as
these materials may play a synergistic role with other
lung pathologies. With respect to pulmonary infections,
MWCNT administration is associated with increased
infectivity of the influenza virus, implying a suppression
of certain host defense mechanisms after MWCNT
exposure [46]. Increased mucus production can exacer-
bate diseases with pathologies that include airway
obstruction by further decreasing airflow. MWCNTs
have been shown to increase mucus production [47],
which has the potential to exacerbate asthma and
Chronic Obstructive Pulmonary Disease. The current
analysis characterizes the biological response to
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MWCNTs, but the extent of the toxic outcomes of this
response may not be fully realized in isolation. The
effects induced in a MWCNT exposed lung in the con-
text of other diseases should be considered to fully
appreciate the breadth of MWCNT-induced pathology.
Conclusions
In summary, the findings of our meta-analysis identified
genes and biological processes involved in two distinct
phases of the pulmonary response to MWCNTs. This re-
sponse was characterized by its similarity to existing
models of lung disease and was distinct from the re-
sponse elicited by nanoTiO2 and CB nanoparticles.
Some of the key genes and GOs identified in this study
are depicted in Fig. 6, which describes a possible mech-
anism of pathology. Inflammation and Th2 responses
have previously been implicated in the progression of
pulmonary fibrosis [27], and the current analysis also
highlights the potential importance of alternatively acti-
vated macrophages in this process. The cluster analysis
provided new insights into the mechanisms of disease
engaged by a nanomaterial capable of inducing fibrosis
and highlighted how these mechanisms are not engaged
by nanoparticles that do not induce fibrosis.
The systematic and comparative meta-profiling of a
small set of publicly available microarray datasets en-
abled characterization of a transcriptional signature that
is shared between various lung disease models and one
that is essential to MWCNT-induced lung fibrosis. The
observation of generalized activation of specific gene
mechanisms regardless of their specific properties sug-
gests that these genes and mechanisms are strongly as-
sociated with lung fibrosis. As the public repository of
transcriptome data becomes populated, the simple
framework described here for comparing and assessing
the intersections of multiple gene expression patterns
from different datasets will enable effective differenti-
ation between the disease inducing and benign ENMs,
and aid in prioritizing of ENMs for further investigation.
It is important to note that the approach proposed is
not an in silico computational approach and requires
tissue-specific gene expression profiling following expos-
ure to novel ENMs. However, it is proposed that the
strategy (short term in vivo tissue transcriptomics com-
bined with meta-analysis) can be used as an effective
first tier screening of new ENMs that exhibit higher po-
tential to induce pulmonary pathology. The study results
presented here reflect lung responses to ENMs in mouse
model. However, many of the significantly perturbed
pro-fibrotic genes and pathways identified are known to
be associated with lung fibrosis in humans. Conditional
to appropriate validation, some of the genes may poten-
tially be used to support future biomonitoring and sur-
veillance efforts for ENMs.
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